Premium
A US state pension fund has invested in a Hyderabad-based active pharmaceutical ingredients (API) maker. This is the latest in a string of deals by investors in the Indian bulk drugs space as pharma giants seek to diversify out of China because of supply chain constraints and souring China-US trade relations. In ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
